Massimo Iavarone

32PUBLICATIONS
152CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Apr 17, 2026
Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group).

|Apr 14, 2026
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach.

Eleonora Alimenti, Massimo Iavarone, Elia Fracas

|Feb 27, 2026
The Predictive Role of [18F]FDG PET/CT in Early HCC Recurrence After Liver Transplantation.

Eleonora Alimenti, Lorenzo Canova, Massimo Iavarone

|Nov 18, 2025
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.

Massimo Iavarone, Eleonora Alimenti, Massimo Puoti

|Aug 12, 2025
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.

Marta Fortuny, Leonardo G da Fonseca, Manon Allaire

|Jul 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma.

Massimo Iavarone, Eleonora Alimenti, Lorenzo Canova

Pageof 6

Frequent Collaborators

13 joint publications

Pietro Lampertico

6 joint publications

Angelo Sangiovanni

5 joint publications

María Reig

4 joint publications

Jean-Charles Nault